Hualan Biological Engineering Inc. (SHE:002007)
15.83
-0.36 (-2.22%)
Jan 28, 2026, 11:34 AM CST
SHE:002007 Market Cap
SHE:002007 has a market cap or net worth of 29.59 billion as of January 27, 2026. Its market cap has decreased by -7.02% in one year.
Market Cap
29.59B
Enterprise Value
27.84B
Revenue
4.27B
Ranking
n/a
PE Ratio
31.18
Stock Price
15.83
Market Cap Chart
Since March 3, 2005, SHE:002007's market cap has increased from 1.18B to 29.59B, an increase of 2,404.77%. That is a compound annual growth rate of 16.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 26, 2026 | 30.52B | 10.38% |
| Dec 31, 2025 | 27.65B | -10.27% |
| Dec 31, 2024 | 30.81B | -23.86% |
| Dec 29, 2023 | 40.47B | -1.97% |
| Dec 30, 2022 | 41.29B | -22.34% |
| Dec 31, 2021 | 53.16B | -31.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai RAAS Blood Products | 42.20B |
| Sunshine Guojian Pharmaceutical (Shanghai) | 39.27B |
| Asymchem Laboratories (Tianjin) | 35.19B |
| Beijing Tiantan Biological Products | 34.45B |
| Xiamen Amoytop Biotech | 31.02B |
| Yili Chuanning Biotechnology | 25.20B |
| Suzhou Zelgen Biopharmaceuticals | 22.86B |
| DaShenLin Pharmaceutical Group | 22.71B |